Author

Weiqi Jiao

Observed name: W. Jiao

Observed institutions: Johns Hopkins University, China Pharmaceutical University, Affiliated Hospital of Qingdao University

ORCID: 0000-0003-3964-2185

Observed ORCID: 0000-0003-3964-2185

OpenAlex ID: A5103250552

Self-assembled block polymer aggregates in selective solution: controllable morphology transitions and their applications in drug delivery

2020 · Weiqi Jiao, Hu Yang, et al. · Expert Opinion on Drug Delivery · 29

The Economic Value and Clinical Impact of Artificial Intelligence in Healthcare: A Scoping Literature Review

2023 · Weiqi Jiao, Xuan Zhang, et al. · IEEE Access · 27

Cost savings through continuous vital sign monitoring in the medical-surgical unit

2023 · John W. Beard, Antra Sethi, et al. · Journal of Medical Economics · 13

81MO Osimertinib as neoadjuvant therapy in patients with EGFR mutated resectable stage II-IIIB lung adenocarcinoma (NEOS): Updated results

2022 · C. Lyu, W. Fang, et al. · Annals of Oncology · 10

Real-World Study of US Adults with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan

2024 · Brian Mulherin, Apeksha Shenoy, et al. · Hematology Reports · 5

Environmental and Economic Impacts of End-tidal Control of Volatile Anesthetics: A Scoping Review and Analysis

2025 · John W. Beard, R. Ross Kennedy, et al. · The Open Anesthesia Journal · 4

Healthcare Resource Utilization and Costs in Patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Treated with Covalent Btki (cBTKi): Real-World Impact of Cardiovascular Adverse Events

2024 · Mavis Obeng-Kusi, Enrico De Nigris, et al. · Blood · 1

Real-world ctDNA test utilization and associated costs in US patients with bladder cancer who underwent radical cystectomy

2026 · Todd M. Morgan, Ching-Yu Wang, et al. · Urologic Oncology Seminars and Original Investigations

Real-world cardiac events and outcomes in cBTKi-treated chronic lymphocytic leukemia patients

2025 · David Dingli, Enrico De Nigris, et al. · Future Oncology

Real-World Clinical Outcomes in Patients Initiating Covalent Btki (cBTKi) with and without Incident Cardiovascular Adverse Events By Line of Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

2024 · David Dingli, Enrico De Nigris, et al. · Blood

Works count: 10

Citation count: 89

H-index: 5

I10-index: 4